Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT00130000 · COMPLETED

Trial details

NCT number: NCT00130000
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Hemoglobinuria, Nocturnal

Start date: 2005-08-09
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.